Cite
HARVARD Citation
Causer, A. et al. (2022). Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Pediatric pulmonology. 57 (11), pp. 2652-2658. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Causer, A. et al. (2022). Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Pediatric pulmonology. 57 (11), pp. 2652-2658. [Online].